Form 8-K - Current report:
SEC Accession No. 0001641172-25-017575
Filing Date
2025-07-02
Accepted
2025-07-02 16:30:18
Documents
19
Period of Report
2025-06-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 68778
2 EX-1.1 ex1-1.htm EX-1.1 222181
3 EX-3.1 ex3-1.htm EX-3.1 115004
4 EX-4.1 ex4-1.htm EX-4.1 96228
5 EX-4.2 ex4-2.htm EX-4.2 87061
6 EX-10.1 ex10-1.htm EX-10.1 280039
7 EX-99.1 ex99-1.htm EX-99.1 14889
8 EX-99.2 ex99-2.htm EX-99.2 12617
  Complete submission text file 0001641172-25-017575.txt   1251706

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE ogen-20250630.xsd EX-101.SCH 3017
10 XBRL LABEL FILE ogen-20250630_lab.xml EX-101.LAB 34239
11 XBRL PRESENTATION FILE ogen-20250630_pre.xml EX-101.PRE 22360
21 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3816
Mailing Address 1990 MAIN STREET SUITE 750 SARASOTA FL 34236
Business Address 1990 MAIN STREET SUITE 750 SARASOTA FL 34236 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

EIN.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32188 | Film No.: 251101663
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)